ULTRALIFE CORP — Director's Dealing 2017

Apr 21, 2017

SEC Form 4/A — Form 4/A

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2010-12-30

Reporting Person: POPIELEC MICHAEL D (Director, Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-12-30	Common Stock; $.10 par value	$6.4218	A	50000	Acquired	2020-12-30	Common Stock; $.10 par value (50000)	Direct

Footnotes

F1: On April 19, 2017, our Board of Directors, on recommendation of the Compensation and Management Committee, extended the option expiration date from December 30, 2017 to December 30, 2020, pursuant to the Company's Amended and Restated 2004 Long-Term Incentive Plan.